An Emerging Leader in the U.S. Pharmaceutical Industry
Solis Pharmaceuticals supports the U.S. pharmaceutical market through U.S. manufacturing, product licensing, strategic marketing, dependable supply, and long-term partnerships, helping bring pharmaceutical products to market with confidence.
Addressing Unmet Market Needs
Building a purpose-driven product pipeline for the evolving U.S. pharmaceutical market.
From Product Licensing to Market Success
Supporting product licensing, strategic marketing, and long-term market growth.
Built in the U.S. Positioned for Growth.
Powered by U.S. manufacturing, dependable supply, and strong market access.
An Emerging Leader in the U.S. Pharmaceutical Industry
Solis Pharmaceuticals is focused on sales, marketing, and distribution of generic and branded medicines across the country. We bring essential treatments to market by combining our own drug approvals (ANDAs) with strategic manufacturing partnerships to serve hospitals, pharmacies, and healthcare systems.
ABOUT SOLIS
A Dynamic Commercial Infrastructure
-
Institutional Reach: Specialized front-end capabilities serving U.S. hospital networks and retail pharmacy chains.
-
Agile Portfolio Growth: Active acquisition, co-development, and in-licensing of marketed and pipeline generic therapeutics.
-
Global Access Engine: Building upon our core U.S. expertise, Solis is selectively extending its reach into high-growth international markets, bringing American-manufactured, FDA-standard prescription therapeutics to global partners who demand uncompromising quality
National Reach. Local Impact.
Supplying generic and branded medicines to health systems and retail partners across the U.S.
Our Business model
Commercialization & Portfolio Expansion Strategy
Solis drives growth through a lean, high-velocity model designed to rapidly scale market access. By combining proactive business development with unmatched U.S. front-end distribution, we structure flexible deals that maximize value for our partners and secure reliable drug supply for healthcare systems.
Joint Ventures
Commercial In-Licensing & Ex-U.S. Out-Licensing
Co-Development
Strategic Acquisitions
Our Products
Commercialized Portfolio & Active Pipeline
Solis Pharmaceuticals manages a robust portfolio of essential prescription therapeutics, oral formulations, sterile injectables, and DEA-controlled products. Backed by rigorous U.S. regulatory standards and seamless front-end distribution, our expanding catalog bridges critical-care support with advanced pipeline developments in targeted therapies, delivering consistent, high-quality pharmaceuticals across commercial, institutional, and nationwide.
Have a Product with a Strong U.S. Market Potential?
Partner with Solis to accelerate commercialization and capture significant market share, delivering life-enhancing therapeutics to the patients who depend on them. Whether you are seeking a trusted U.S. distribution engine, an in-licensing collaborator, or a transaction-ready portfolio acquirer, our commercial leadership team brings the market access and execution speed needed to maximize your product’s value.
